<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="sox2" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">sox2</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">SOX2</italic>-Related Eye Disorders</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Williamson</surname>
            <given-names>Kathleen A</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>MRC Human Genetics Unit<break/>MRC Institute of Genetics and Molecular Medicine<break/>University of Edinburgh<break/>Edinburgh, United Kingdom</aff>
          <email>kathy.williamson@igmm.ed.ac.uk</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>FitzPatrick</surname>
            <given-names>David R</given-names>
          </name>
          <degrees>MD, FRCP(EDIN)</degrees>
          <aff>Consultant in Pediatric Genetics, MRC Human Genetics Unit<break/>MRC Institute of Genetics and Molecular Medicine<break/>University of Edinburgh<break/>Edinburgh, United Kingdom</aff>
          <email>david.fitzpatrick@ed.ac.uk</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2006-02-23" date-type="created">
          <day>23</day>
          <month>2</month>
          <year>2006</year>
        </date>
        <date iso-8601-date="2014-07-31" date-type="updated">
          <day>31</day>
          <month>7</month>
          <year>2014</year>
        </date>
        <date iso-8601-date="2008-03-07" date-type="revised">
          <day>7</day>
          <month>3</month>
          <year>2008</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="sost" document-type="chapter"><italic toggle="yes">SOST</italic>-Related Sclerosing Bone Dysplasias</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="stxbp1-ee" document-type="chapter"><italic toggle="yes">STXBP1</italic> Encephalopathy with Epilepsy</related-object>
      <abstract id="sox2.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">SOX2</italic>-related eye disorders are characterized by anophthalmia and/or microphthalmia that is usually bilateral, severe, and apparent at birth or by prenatal ultrasound examination. Other common findings include brain malformations, esophageal atresia, cryptorchidism and/or micropenis in males, and hypogonadotropic hypogonadism and/or pituitary hypoplasia. Postnatal growth failure, delayed motor development, and learning disability are common.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of <italic toggle="yes">SOX2</italic>-related eye disorders is established by clinical findings, cytogenetic or molecular analysis to detect deletions of 3q27 (which includes <italic toggle="yes">SOX2</italic>), and molecular genetic testing. Molecular genetic testing identifies a heterozygous <italic toggle="yes">SOX2</italic> pathogenic variant in approximately 40% of individuals with bilateral anophthalmia/microphthalmia.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Use of optically clear expanders to stimulate growth of the orbit and periorbital tissues; special educational services for visually impaired infants and children; physiotherapy for motor impairment; special education for neurodevelopmental problems; use of melatonin for abnormal sleep patterns; antiepileptic drugs for seizure management.</p>
          <p><italic toggle="yes">Surveillance:</italic> Annual hearing test and annual neurodevelopmental assessment until age five years; measurement of height, weight, and head circumference every three to six months during childhood.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">SOX2</italic>-related eye disorders are inherited in an autosomal dominant manner, most often resulting from a <italic toggle="yes">de novo</italic> pathogenic variant. The risk to the sibs of a proband is usually small; however, if a parent of a proband has germline mosaicism, the risk to the sibs may be as high as 50%. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant in the family is known. Fetal ultrasound examination reveals marked reduction in the size of the globes.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="sox2.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="sox2.Tc" position="anchor" orientation="portrait">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_sox2.Tc_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">SOX2</italic>-Related Eye Disorders: Included Phenotypes</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_sox2.Tc_1_1_1_1" valign="top" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p><italic toggle="yes">SOX2</italic> anophthalmia syndrome</p>
                    </list-item>
                    <list-item>
                      <p>Anophthalmia-esophageal atresia-genital abnormalities (AEG) syndrome</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="sox2.Nomenclature">Nomenclature</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="sox2.Diagnosis">
        <title>Diagnosis</title>
        <sec id="sox2.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Diagnosis of <italic toggle="yes">SOX2</italic>-related eye disorders should be suspected in individuals with:</p>
          <list list-type="bullet">
            <list-item>
              <p>Bilateral anophthalmia and/or microphthalmia</p>
            </list-item>
            <list-item>
              <p>Unilateral anophthalmia or microphthalmia</p>
            </list-item>
            <list-item>
              <p>Cryptorchidism and/or micropenis in males</p>
            </list-item>
            <list-item>
              <p>Malformation and/or heterotopia of the mesial temporal structures of the brain, particularly the hippocampus</p>
            </list-item>
            <list-item>
              <p>Tracheoesophageal fistula and/or esophageal atresia</p>
            </list-item>
            <list-item>
              <p>Learning disability</p>
            </list-item>
            <list-item>
              <p>Delayed motor development</p>
            </list-item>
            <list-item>
              <p>Postnatal growth failure</p>
            </list-item>
            <list-item>
              <p>Hypogonadotropic hypogonadism with or without pituitary hypoplasia</p>
            </list-item>
          </list>
        </sec>
        <sec id="sox2.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of <italic toggle="yes">SOX2</italic>-related eye disorders <bold>is established</bold> in a proband by genetic testing to detect deletions, chromosome translocation, or pathogenic variation involving <italic toggle="yes">SOX2</italic>.</p>
          <p><bold>Cytogenetic analysis</bold> includes chromosome analysis and copy number variant analyses including array comparative genomic hybridization (aCGH) and high-resolution detection of microdeletions known to occur in 15% of patients.</p>
          <list list-type="bullet">
            <list-item>
              <p>Cytogenetically visible deletions of 3q27 known to include deletion of <italic toggle="yes">SOX2</italic> have been observed [<xref ref-type="bibr" rid="sox2.REF.male.2002.807">Male et al 2002</xref>, <xref ref-type="bibr" rid="sox2.REF.guichet.2004.828">Guichet et al 2004</xref>, <xref ref-type="bibr" rid="sox2.REF.kelberman.2008.1865">Kelberman et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">De novo</italic> apparently balanced translocations involving 3q27 have been detected in others [<xref ref-type="bibr" rid="sox2.REF.kurbasic.2000.239">Kurbasic et al 2000</xref>], including loss of the entire <italic toggle="yes">SOX2</italic> gene in a t(3;11)(q26.3;p11.2)-associated 600-kb microdeletion [<xref ref-type="bibr" rid="sox2.REF.fantes.2003.461">Fantes et al 2003</xref>] and a t(3;7)(q28;p21.3) associated 2.7-Mb deletion [<xref ref-type="bibr" rid="sox2.REF.williamson.2006.1413">Williamson et al 2006</xref>].</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">De novo</italic> microdeletions encompassing <italic toggle="yes">SOX2</italic> are relatively common disease-causing alleles [<xref ref-type="bibr" rid="sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</xref>].</p>
            </list-item>
          </list>
          <p><bold>Molecular analysis</bold> (see <xref ref-type="table" rid="sox2.T.summary_of_molecular_genetic_test">Table 1</xref>) can include <bold>single-gene testing</bold> and use of a <bold>multi-gene panel</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">SOX2</italic> is often performed first, followed by deletion/duplication analysis if no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A</bold>
<bold>multi-gene panel</bold> that includes <italic toggle="yes">SOX2</italic> and other genes of interest (see <xref ref-type="sec" rid="sox2.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost.</p>
            </list-item>
          </list>
          <table-wrap id="sox2.T.summary_of_molecular_genetic_test" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in <italic toggle="yes">SOX2</italic>-Related Eye Disorders</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_sox2.T.summary_of_molecular_genetic_test_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_sox2.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_sox2.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_sox2.T.summary_of_molecular_genetic_test_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">SOX2</italic>
                  </td>
                  <td headers="hd_h_sox2.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_sox2.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">25%-30%&#x000a0;<sup>3</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_sox2.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_sox2.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">7%-10%&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_sox2.T.summary_of_molecular_genetic_test_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">FISH&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_sox2.T.summary_of_molecular_genetic_test_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">4%&#x000a0;<sup>3,&#x000a0;6</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="sox2.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="sox2" object-id="sox2.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein name. See <xref ref-type="sec" rid="sox2.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="sox2.TF.1.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="sox2.TF.1.3">
                <label>3. </label>
                <p>Screening of &#x0003e;1000 individuals with severe eye malformations using a combination of scanning of the entire coding region for pathogenic variants, direct sequencing of the entire coding region, high-resolution copy number variant analyses, and FISH analysis for large-scale deletions detects <italic toggle="yes">SOX2</italic> pathogenic variants in 25%-30% of individuals, including 40% of individuals with <bold>bilateral</bold> anophthalmia/microphthalmia and &#x0003c;3% of individuals with <bold>unilateral</bold> eye involvement [<xref ref-type="bibr" rid="sox2.REF.chassaing.2013">Chassaing et al 2013</xref>, <xref ref-type="bibr" rid="sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</xref>, <xref ref-type="bibr" rid="sox2.REF.williamson.2014">Williamson &#x00026; FitzPatrick 2014</xref>].</p>
              </fn>
              <fn id="sox2.TF.1.4">
                <label>4. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="sox2.TF.1.5">
                <label>5. </label>
                <p>Detection frequency is 7%-10% for deletions in cases with severe microphthalmia or anophthalmia [<xref ref-type="bibr" rid="sox2.REF.bakrania.2007.1471">Bakrania et al 2007</xref>, <xref ref-type="bibr" rid="sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</xref>, <xref ref-type="bibr" rid="sox2.REF.schilter.2013.473">Schilter et al 2013</xref>]. No duplications have been identified.</p>
              </fn>
              <fn id="sox2.TF.1.6">
                <label>6. </label>
                <p>Large (partial- and whole-gene) deletions. Detection frequency is 4% [<xref ref-type="bibr" rid="sox2.REF.bakrania.2007.1471">Bakrania et al 2007</xref>].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="sox2.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="sox2.Clinical_Description">
          <title>Clinical Description</title>
          <p>A total of 114 individuals from 97 families with <italic toggle="yes">SOX2</italic>-related eye defects have been studied in detail to date [<xref ref-type="bibr" rid="sox2.REF.williamson.2014">Williamson &#x00026; FitzPatrick 2014</xref>].</p>
          <p><bold>Bilateral anophthalmia and/or microphthalmia.</bold>
<italic toggle="yes">SOX2</italic>-related eye defects are usually bilateral, severe, and apparent at birth or on routine prenatal ultrasound examination. In the 114 individuals reported to date, 56 (49%) had bilateral anophthalmia, 19 (17%) had anophthalmia with contralateral microphthalmia, and 12 (10%) had bilateral microphthalmia. The remaining individuals have a wide spectrum of eye malformations including the following [<xref ref-type="bibr" rid="sox2.REF.williamson.2014">Williamson &#x00026; FitzPatrick 2014</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Unilateral anopthalmia or microphthalmia and a normal eye</p>
            </list-item>
            <list-item>
              <p>Unilateral microphthalmia with coloboma or iris defect in the contralateral eye</p>
            </list-item>
            <list-item>
              <p>Coloboma</p>
            </list-item>
            <list-item>
              <p>Optic nerve hypoplasia</p>
            </list-item>
            <list-item>
              <p>Cataract</p>
            </list-item>
            <list-item>
              <p>Retinal dysplasia</p>
            </list-item>
            <list-item>
              <p>Anterior segment dysgenesis (including sclerocornea or microcornea)</p>
            </list-item>
            <list-item>
              <p>Refractive error</p>
            </list-item>
          </list>
          <p>Three individuals with loss-of-function pathogenic variants had bilateral structurally normal eyes. These individuals were: a monozygotic twin with tracheoesophageal fistula and unilateral reduced palpebral fissure (the other twin had anophthalmia-esophageal atresia-genital abnormalities [AEG] syndrome with unilateral anophthalmia) [<xref ref-type="bibr" rid="sox2.REF.zenteno.2006.1899">Zenteno et al 2006</xref>]; a sibling fetus in a family with AEG syndrome, with brain anomalies and 11 rib pairs [<xref ref-type="bibr" rid="sox2.REF.chassaing.2007.289">Chassaing et al 2007</xref>]; and a mother (with heterozygosity or a high level of mosaicism of the pathogenic variant) with isolated hypogonadotropic hypogonadism who, following assisted conception, had two children with bilateral anophthalmia or unilateral microphthalmia with coloboma [<xref ref-type="bibr" rid="sox2.REF.stark.2011.753">Stark et al 2011</xref>].</p>
          <p>The degree of visual impairment is usually severe and consistent with the degree of structural abnormality in the eye. In general, retina tissue that is present has some functional activity. For example, even in extreme microphthalmia, functional retinal tissue can give some light/dark perception with or without color perception.</p>
          <p><bold>Brain malformation.</bold> Twelve children had mesial temporal (hippocampal and parahippocampal) malformations evident on MRI. Two also had evidence of heterotopic grey matter in the mesial temporal region [<xref ref-type="bibr" rid="sox2.REF.sisodiya.2006.534">Sisodiya et al 2006</xref>]. Pituitary hypoplasia and agenesis or dysgenesis of the corpus callosum have been reported in multiple individuals [<xref ref-type="bibr" rid="sox2.REF.guichet.2004.828">Guichet et al 2004</xref>, <xref ref-type="bibr" rid="sox2.REF.ragge.2005a.1008">Ragge et al 2005a</xref>, <xref ref-type="bibr" rid="sox2.REF.zenteno.2005.564">Zenteno et al 2005</xref>, <xref ref-type="bibr" rid="sox2.REF.hever.2006.459">Hever et al 2006</xref>, <xref ref-type="bibr" rid="sox2.REF.kelberman.2006.2442">Kelberman et al 2006</xref>, <xref ref-type="bibr" rid="sox2.REF.williamson.2006.1413">Williamson et al 2006</xref>, <xref ref-type="bibr" rid="sox2.REF.bakrania.2007.1471">Bakrania et al 2007</xref>, <xref ref-type="bibr" rid="sox2.REF.kelberman.2008.1865">Kelberman et al 2008</xref>, <xref ref-type="bibr" rid="sox2.REF.zhou.2008.583">Zhou et al 2008</xref>, <xref ref-type="bibr" rid="sox2.REF.schneider.2009.2706">Schneider et al 2009</xref>, <xref ref-type="bibr" rid="sox2.REF.gonzalezrodriguez.2010.1100">Gonzalez-Rodriguez et al 2010</xref>, <xref ref-type="bibr" rid="sox2.REF.chassaing.2013">Chassaing et al 2013</xref>, <xref ref-type="bibr" rid="sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</xref>, <xref ref-type="bibr" rid="sox2.REF.macchiaroli.2014.282">Macchiaroli et al 2014</xref>].</p>
          <p><bold>Anterior pituitary hypoplasia.</bold> The majority of cases have some evidence of hypothalamo-pituitary axis dysfunction when detailed measurement of growth hormone and gonadotrophins are undertaken [<xref ref-type="bibr" rid="sox2.REF.tziaferi.2008.194">Tziaferi et al 2008</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Postnatal growth failure.</bold> Birth weight in most infants is normal for gestational age. However, most children have a reduced growth velocity in the first years of life resulting in symmetric growth failure.</p>
            </list-item>
            <list-item>
              <p><bold>Hypogonadotropic hypogonadism.</bold> This feature is reported in 17 individuals, including one mother with normal eyes [<xref ref-type="bibr" rid="sox2.REF.stark.2011.753">Stark et al 2011</xref>] and one male with unilateral retinal detachment, micropenis, and cryptorchidism [<xref ref-type="bibr" rid="sox2.REF.takagi.2014.133">Takagi et al 2014</xref>].</p>
            </list-item>
            <list-item>
              <p><bold>Genital abnormalities.</bold> Micropenis, hypospadias, and cryptorchidism were frequent abnormalities in male cases, whereas hypoplastic uterus and ovarian agenesis were rare features in female cases.</p>
            </list-item>
          </list>
          <p><bold>Delayed motor development</bold> was reported in the majority of cases; the age of achieving independent walking ranged from 12 months to four years, although some individuals never achieve independent ambulation.</p>
          <p><bold>Learning disability</bold> is highly variable and ranged from normal intelligence to severe learning disability, with the majority of those tested scoring between these extremes. The degree of learning disability is not predictable by mutation type or severity of the eye involvement.</p>
          <p><bold>Seizures</bold> were observed in 16 individuals; onset is variable, but common in early childhood. Information on the exact seizure type is limited, but most appeared to be grand mal tonic-clonic seizures, which appeared in early childhood and responded well to standard anticonvulsant medication.</p>
          <p><bold>Sensorineural hearing loss.</bold> Five children had apparently non-progressive moderate sensorineural hearing loss requiring hearing aids.</p>
          <p><bold>Esophageal atresia with or without tracheoesophageal fistula.</bold> Heterozygous pathogenic variants in <italic toggle="yes">SOX2</italic> have been identified in eight unrelated individuals and monozygotic twins with AEG syndrome (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/206900">OMIM</ext-link>) [<xref ref-type="bibr" rid="sox2.REF.kelberman.2006.2442">Kelberman et al 2006</xref>, <xref ref-type="bibr" rid="sox2.REF.williamson.2006.1413">Williamson et al 2006</xref>, <xref ref-type="bibr" rid="sox2.REF.zenteno.2006.1899">Zenteno et al 2006</xref>, <xref ref-type="bibr" rid="sox2.REF.bakrania.2007.1471">Bakrania et al 2007</xref>, <xref ref-type="bibr" rid="sox2.REF.chassaing.2007.289">Chassaing et al 2007</xref>, <xref ref-type="bibr" rid="sox2.REF.chassaing.2013">Chassaing et al 2013</xref>]. AEG syndrome does not appear to be a distinct entity, but rather part of the spectrum of <italic toggle="yes">SOX2</italic>-related eye disorders.</p>
        </sec>
        <sec id="sox2.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Almost all <italic toggle="yes">SOX2</italic> pathogenic variants reported to date appear to represent heterozygous loss of function; thus, it is difficult to draw genotype-phenotype correlations.</p>
          <p>Penetrance appears to be complete for non-mosaic loss-of-function pathogenic variants. Variable expressivity is a feature observed with some pathogenic variants, such as the most common variant allele that alters the N-terminal region polyglycine repeat [<xref ref-type="bibr" rid="sox2.REF.zenteno.2006.1899">Zenteno et al 2006</xref>, <xref ref-type="bibr" rid="sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</xref>], and the recurrent variant allele that alters a specific residue in the partner-binding domain [<xref ref-type="bibr" rid="sox2.REF.mihelec.2009.1417">Mihelec et al 2009</xref>, <xref ref-type="bibr" rid="sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</xref>].</p>
        </sec>
        <sec id="sox2.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance appears to be complete for non-mosaic loss-of-function pathogenic variants.</p>
        </sec>
        <sec id="sox2.Nomenclature">
          <title>Nomenclature</title>
          <p>The condition has also been called <italic toggle="yes">SOX2</italic> anophthalmia syndrome [<xref ref-type="bibr" rid="sox2.REF.ragge.2005b.1">Ragge et al 2005b</xref>].</p>
          <p>Microphthalmia-anophthalmia-coloboma (MAC) was used as an umbrella term for the spectrum of severe eye malformations in some early publications describing <italic toggle="yes">SOX2</italic>-related eye disorders. This may be an inappropriate acronym as it implies that coloboma is an intrinsic part of all microphthalmia, which no longer appears to be the case.</p>
          <p>Each of the hypothetic explanations for the embryonic origin of the small or missing eyes associated with <italic toggle="yes">SOX2</italic> pathogenic variants predicts a different spectrum of clinical phenotypes.</p>
          <list list-type="bullet">
            <list-item>
              <p>If the primary defect were in the mechanism of optic fissure closure, the predicted order of severity would be iris coloboma, choroidal/retinal coloboma, microphthalmia with coloboma or orbital cyst, and anophthalmia.</p>
            </list-item>
            <list-item>
              <p>If lens induction were impaired, the predicted clinical spectrum would be congenital cataract &#x0003e; microphthalmia &#x0003e; anophthalmia.</p>
            </list-item>
            <list-item>
              <p>If the main effects of <italic toggle="yes">SOX2</italic> were in retinal differentiation, the predicted clinical manifestations would be retinal dystrophy &#x0003e; microphthalmia.</p>
            </list-item>
            <list-item>
              <p>It is also possible that complete failure of optic vesicle formation results in anophthalmia without optic nerve formation.</p>
            </list-item>
          </list>
          <p>Thus, the term MAC has inadequate descriptive power to be useful. The particular spectrum associated with <italic toggle="yes">SOX2</italic>-related eye disorders is not yet clear because most affected individuals have very small or absent eyes, which are thus morphologically unclassifiable. Coloboma has been reported but is not a common feature.</p>
          <p>Anophthalmia-esophageal atresia-genital abnormalities (AEG) syndrome was previously reported to be a distinct disorder, but is now known to be associated with heterozygous pathogenic loss-of-function variants in <italic toggle="yes">SOX2</italic> in some individuals [<xref ref-type="bibr" rid="sox2.REF.williamson.2006.1413">Williamson et al 2006</xref>, <xref ref-type="bibr" rid="sox2.REF.zenteno.2006.1899">Zenteno et al 2006</xref>]; thus, it appears that esophageal atresia with or without tracheoesophageal fistula is a feature of <italic toggle="yes">SOX2</italic>-related eye disorders and not a separate condition. This is consistent with the known expression of <italic toggle="yes">SOX2</italic> in the endoderm and genital ridge during development of chick and mouse embryos.</p>
        </sec>
        <sec id="sox2.Prevalence">
          <title>Prevalence</title>
          <p>Prevalence is approximately 1:250,000 (UK estimate) [Author, personal data].</p>
        </sec>
      </sec>
      <sec id="sox2.Genetically_Related_Allelic_Disorde">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">SOX2</italic>.</p>
      </sec>
      <sec id="sox2.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><italic toggle="yes">SOX2</italic> pathogenic variants account for 40% of bilateral anophthalmia, making it the most frequent known genetic cause of severe bilateral eye malformations. However, these disorders show marked etiologic heterogeneity.</p>
        <p><italic toggle="yes">OTX2</italic> anophthalmia syndrome (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/610125">OMIM</ext-link>), caused by heterozygous pathogenic loss-of-function variants in <italic toggle="yes">OTX2</italic>, can present with almost identical ocular and brain features to <italic toggle="yes">SOX2</italic> anophthalmia syndrome [<xref ref-type="bibr" rid="sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</xref>]. However, esophageal atresia and tracheoesophageal fistula have not been described in association with mutation of <italic toggle="yes">OTX2</italic>.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="charge" document-type="chapter">CHARGE syndrome</related-object> should be considered in children with ocular malformations, growth deficiency, micropenis, and tracheaesophageal fistula. Sequence analysis of <italic toggle="yes">CHD7</italic> in individuals with either typical CHARGE syndrome or a milder phenotype (i.e., fewer major characteristics) detects pathogenic variants in approximately 65%-70% of cases. In one individual with AEG syndrome in whom no <italic toggle="yes">SOX2</italic> pathogenic variant was identified a heterozygous loss-of-function pathogenic variant in <italic toggle="yes">CHD7</italic> has subsequently been identified [Williamson &#x00026; FitzPatrick, unpublished].</p>
        <p>One rather poorly defined condition that may resemble <italic toggle="yes">SOX2</italic>-related eye disorders is <related-object link-type="booklink" source-id="gene" document-id="lenz" document-type="chapter">Lenz microphthalmia syndrome</related-object> (LMS), characterized by unilateral or bilateral microphthalmia and/or anophthalmia with malformations of the ears, teeth, fingers, skeleton, or genitourinary system. Approximately 60% of affected males have mild-to-severe intellectual disability or developmental delay. Two loci on the X chromosome, MCOPS1 and MCOPS2, are known to be associated with LMS. The LMS-associated gene on MCOPS2 is <italic toggle="yes">BCOR</italic>. Inheritance is X-linked.</p>
        <p>See <related-object link-type="booklink" source-id="gene" document-id="anophthalmia-ov" document-type="chapter">Anophthalmia/Microphthalmia Overview</related-object> for a more complete differential diagnosis. Pathogenic variants in <italic toggle="yes">CHX10, RAX, PAX6</italic> (see <related-object link-type="booklink" source-id="gene" document-id="aniridia" document-type="chapter">Aniridia</related-object>), and <italic toggle="yes">OTX2</italic> can have overlapping phenotypes.</p>
        <p>See <related-object link-type="booklink" source-id="gene" document-id="tef-ov" document-type="chapter">Esophageal Atresia/Tracheoesophageal Fistula Overview</related-object> for a more complete differential diagnosis.</p>
      </sec>
      <sec id="sox2.Management">
        <title>Management</title>
        <sec id="sox2.Evaluations_Following_Initial_Diagn">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with a <italic toggle="yes">SOX2</italic>-related eye disorder, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Examination by an experienced pediatric ophthalmologist</p>
            </list-item>
            <list-item>
              <p>High-resolution cranial MRI for brain/pituitary malformations, optic nerve/chiasm/tract assessment</p>
            </list-item>
            <list-item>
              <p>Endocrinologic evaluation to include corticosteroid, gonadotrphin, growth hormone, and thyroid function tests to assess pituitary function</p>
            </list-item>
            <list-item>
              <p>Baseline neurodevelopmental assessment</p>
            </list-item>
            <list-item>
              <p>Audiometry</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="sox2.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Visual impairment.</bold> The general management of visual impairment is not specific to anophthalmia or microphthalmia (see <related-object link-type="booklink" source-id="gene" document-id="anophthalmia-ov" document-type="chapter">Anophthalmia/Microphthalmia Overview</related-object>). Care includes:</p>
          <list list-type="bullet">
            <list-item>
              <p>Early referral to an experienced multidisciplinary team</p>
            </list-item>
            <list-item>
              <p>Consideration of use of expanders to stimulate growth of the orbit and periorbital tissues. Because accurate assessment of visual function is necessary, optically clear expanders should be used.</p>
            </list-item>
            <list-item>
              <p>Referral to special educational services for visually impaired infants</p>
            </list-item>
          </list>
          <p>
            <bold>Other</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Referral to endocrinologist for growth or hypogonadism concerns</p>
            </list-item>
            <list-item>
              <p>Referral to physiotherapist if any evidence of motor impairment exists</p>
            </list-item>
            <list-item>
              <p>Referral to special educational services for neurodevelopmental problems as needed</p>
            </list-item>
            <list-item>
              <p>Consideration of use of melatonin for regulation of circadian rhythm if sleep pattern is abnormal</p>
            </list-item>
            <list-item>
              <p>Parent/caregiver training in seizure management</p>
            </list-item>
          </list>
        </sec>
        <sec id="sox2.Prevention_of_Secondary_Complicatio">
          <title>Prevention of Secondary Complications</title>
          <p>Many neonates can have an adequate MRI without general anesthesia using the &#x0201c;feed and wrap&#x0201d; method. In this case, assess morning cortisol levels prior to any subsequent anesthetic if this MRI reveals pituitary hypoplasia. If an anesthetic is required before adequate intracranial imaging is available, an endocrinologic evaluation is indicated.</p>
        </sec>
        <sec id="sox2.Surveillance">
          <title>Surveillance</title>
          <p>The following measures are suggested:</p>
          <list list-type="bullet">
            <list-item>
              <p>Annual hearing test</p>
            </list-item>
            <list-item>
              <p>Measurement of height, weight, and head circumference every three to six months during childhood</p>
            </list-item>
            <list-item>
              <p>Neurodevelopmental assessment annually for the first five years of life</p>
            </list-item>
          </list>
        </sec>
        <sec id="sox2.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="sox2.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="sox2.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="sox2.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="sox2.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">SOX2</italic>-related eye disorders are inherited in an autosomal dominant manner, most often resulting from a <italic toggle="yes">de novo</italic> pathogenic variant. Rarely, parental germline mosaicism can result in a "pseudo-autosomal recessive" pattern of inheritance [<xref ref-type="bibr" rid="sox2.REF.faivre.2006.636">Faivre et al 2006</xref>, <xref ref-type="bibr" rid="sox2.REF.schneider.2008.2794">Schneider et al 2008</xref>, <xref ref-type="bibr" rid="sox2.REF.zhou.2008.583">Zhou et al 2008</xref>, <xref ref-type="bibr" rid="sox2.REF.schneider.2009.2706">Schneider et al 2009</xref>].</p>
        </sec>
        <sec id="sox2.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>A proband with a <italic toggle="yes">SOX2</italic>-related eye disorder most often has the disorder as the result of a <italic toggle="yes">de novo</italic> heterozygous pathogenic variant. In such cases, both parents are unaffected and do not have a <italic toggle="yes">SOX2</italic> pathogenic variant. The proportion of cases known to be caused by a <italic toggle="yes">de novo</italic> pathogenic variant is 60%.</p>
            </list-item>
            <list-item>
              <p>Autosomal dominant transmission has been reported.</p>
              <list list-type="bullet">
                <list-item>
                  <p>One individual diagnosed with unilateral anophthalmia had a similarly affected mother [<xref ref-type="bibr" rid="sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</xref>].</p>
                </list-item>
                <list-item>
                  <p>Maternal transmission of a pathogenic variant was observed in a four-generation family with eye defects ranging from microcornea or retinal tuft with refractive error to bilateral anophthalmia [<xref ref-type="bibr" rid="sox2.REF.mihelec.2009.1417">Mihelec et al 2009</xref>], and in a mother and child with bilateral coloboma and bilateral anopthalmia/microphthalmia with coloboma, respectively [<xref ref-type="bibr" rid="sox2.REF.gerthkahlert.2013.15">Gerth-Kahlert et al 2013</xref>].</p>
                </list-item>
                <list-item>
                  <p>A mother with a <italic toggle="yes">SOX2</italic> pathogenic variant affected with isolated hypogonadotropic hypogonadism had two affected children: a son with bilateral anophthalmia and subtle endocrine abnormalities and a daughter with unilateral microphthalmia with coloboma [<xref ref-type="bibr" rid="sox2.REF.stark.2011.753">Stark et al 2011</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Germline mosaicism has been reported.</p>
              <list list-type="bullet">
                <list-item>
                  <p>Phenotypically normal parents may have germline mosaicism for a pathogenic variant.</p>
                  <list list-type="bullet">
                    <list-item>
                      <p>Recurrence of anophthalmia and/or microphthalmia has been reported in four families in which the phenotypically normal mother had germline mosaicism that was either detected [<xref ref-type="bibr" rid="sox2.REF.faivre.2006.636">Faivre et al 2006</xref>, <xref ref-type="bibr" rid="sox2.REF.schneider.2008.2794">Schneider et al 2008</xref>, <xref ref-type="bibr" rid="sox2.REF.zhou.2008.583">Zhou et al 2008</xref>, <xref ref-type="bibr" rid="sox2.REF.schneider.2009.2706">Schneider et al 2009</xref>] or was probable but undetected [<xref ref-type="bibr" rid="sox2.REF.schneider.2009.2706">Schneider et al 2009</xref>].</p>
                    </list-item>
                    <list-item>
                      <p>Germline mosaicism was identified in the mother of two sibs, both with a pathogenic variant, and bilateral anophthalmia or normal eyes [<xref ref-type="bibr" rid="sox2.REF.chassaing.2007.289">Chassaing et al 2007</xref>, <xref ref-type="bibr" rid="sox2.REF.chassaing.2013">Chassaing et al 2013</xref>].</p>
                    </list-item>
                  </list>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include detailed ophthalmologic examination of the parents and, if the pathogenic variant in the proband has been identified, molecular genetic testing of DNA ideally extracted from more than one tissue source (e.g., leukocytes and buccal cells).</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
          <list list-type="bullet">
            <list-item>
              <p>Because <italic toggle="yes">SOX2</italic>-related eye disorders typically occur as the result of a <italic toggle="yes">de novo</italic> pathogenic variant, the risk to the sibs of a proband is usually small.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected and/or has a <italic toggle="yes">SOX2</italic> pathogenic variant, the risk to the sibs of inheriting the <italic toggle="yes">SOX2</italic> pathogenic variant is 50%.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband has germline mosaicism, the risk to the sibs of inheriting the <italic toggle="yes">SOX2</italic> pathogenic variant may be up to 50%.</p>
            </list-item>
            <list-item>
              <p>The incidence of germline mosaicism for <italic toggle="yes">SOX2</italic>-related eye disorders is approximately 6%. Germline mosaicism can result in a "pseudo-autosomal recessive" pattern of inheritance [<xref ref-type="bibr" rid="sox2.REF.faivre.2006.636">Faivre et al 2006</xref>, <xref ref-type="bibr" rid="sox2.REF.schneider.2008.2794">Schneider et al 2008</xref>, <xref ref-type="bibr" rid="sox2.REF.zhou.2008.583">Zhou et al 2008</xref>, <xref ref-type="bibr" rid="sox2.REF.schneider.2009.2706">Schneider et al 2009</xref>].</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with a <italic toggle="yes">SOX2</italic>-related eye disorder has a 50% chance of inheriting the <italic toggle="yes">SOX2</italic> pathogenic variant.</p>
          <p><bold>Other family members of a proband.</bold> Because the majority of <italic toggle="yes">SOX2</italic>-related eye disorders occur as the result of a fully penetrant <italic toggle="yes">de novo</italic> pathogenic variant, unaffected family members other than parents of a proband are not at increased risk. Variable expressivity can result in relatively mild phenotypes in rare cases.</p>
        </sec>
        <sec id="sox2.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, the <italic toggle="yes">SOX2</italic> pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="sox2.Prenatal_Testing_and_Preimplantatio">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p><bold>Molecular genetic testing.</bold> If the <italic toggle="yes">SOX2</italic> pathogenic variant has been identified in an affected family member, prenatal testing and preimplantation genetic diagnosis for a pregnancy at increased risk for a <italic toggle="yes">SOX2</italic>-related eye disorder are possible options. However, severity of disease and specific clinical findings are variable and cannot be accurately predicted by the family history or results of molecular genetic testing.</p>
          <p><bold>Fetal ultrasound examination/fetal MRI</bold> is also possible as the eye malformations in fetuses with <italic toggle="yes">SOX2</italic>-related eye disorders (bilateral anophthalmia or severe microphthalmia) are usually severe and can be detected during the second trimester of pregnancy using fetal ultrasound.</p>
        </sec>
      </sec>
      <sec id="sox2.Resources">
        <title>Resources</title>
      </sec>
      <sec id="sox2.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold> The coding region comprises one exon. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="sox2" object-id="sox2.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Benign allelic variants.</bold> The NHLBI Exome Sequencing Project <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">Exome Variant Server</ext-link>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://evs.gs.washington.edu/EVS/">http://evs.gs.washington.edu/EVS/</ext-link>(accessed 6-14) lists seven benign variants that do not alter the primary protein sequence, and seven variants that are likely benign or of unknown significance and that are predicted to substitute residues in the transactivation domain of SOX-2. There are no variants of these types known to affect the HMG domain or the partner-binding domain. The <italic toggle="yes">SOX</italic> genes are defined as having greater than 60% homology within the HMG domain to human <italic toggle="yes">SRY</italic>. Within the <italic toggle="yes">SOX</italic> family, <italic toggle="yes">SOX2</italic> belongs to the <italic toggle="yes">SOXB</italic> subgroup with <italic toggle="yes">SOX1</italic>, <italic toggle="yes">SOX3</italic>, <italic toggle="yes">SOX14</italic>, and <italic toggle="yes">SOX21</italic>.</p>
        <p><bold>Pathogenic allelic variants.</bold> All <italic toggle="yes">SOX2</italic> pathogenic variants identified to date result in apparent loss of function. The most common variant types are nonsense and frameshift. Five alleles, predicted to frameshift the codons of an N-terminal region polyglycine repeat, account for almost one fifth of the pathogenic variants in individuals and families. The remaining known pathogenic variants are nonsynonymous, in-frame insertion, and whole-gene deletion alleles. Details of all the known pathogenic variants are available in an online <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://lsdb.hgu.mrc.ac.uk/home.php?select_db=SOX2"><italic toggle="yes">SOX2</italic> mutation database</ext-link>.</p>
        <p><bold>Normal gene product.</bold> Transcription factor SOX-2 is a 317-amino acid peptide. It has an HMG DNA-binding domain (amino acids 40-111), a partner-binding domain and a C-terminal transactivation domain. The N-terminal region is of unknown function and contains short polyglycine and polyalanine repeats.</p>
        <p><italic toggle="yes">SOX2</italic> is expressed in mouse embryonic stem cells and has been shown to act as part of a transcriptional activator complex for several important developmental genes [<xref ref-type="bibr" rid="sox2.REF.ambrosetti.2000.23387">Ambrosetti et al 2000</xref>, <xref ref-type="bibr" rid="sox2.REF.tomioka.2002.3202">Tomioka et al 2002</xref>] including other genes known to be critical to eye development (e.g., <italic toggle="yes">PAX6</italic> and <italic toggle="yes">MAF1</italic>) [<xref ref-type="bibr" rid="sox2.REF.kamachi.2001.1272">Kamachi et al 2001</xref>, <xref ref-type="bibr" rid="sox2.REF.muta.2002.791">Muta et al 2002</xref>]. It is an early marker of neurulation in chick embryos and shows site- and stage-specific expression in the developing nervous system, genital ridge, and foregut in all vertebrates studied.</p>
        <p><bold>Abnormal gene product.</bold> As <italic toggle="yes">SOX2</italic> is a single-exon gene, it is not subject to nonsense-mediated decay and it is possible that truncated peptide may be produced in affected individuals. If these abnormal peptides were stable, they could have a dominant-negative effect. However, with the increase in the number of variant alleles known, differences between the clinical features of those with whole-gene deletions and those with stop gain pathogenic variants are not evident, suggesting that there is no dominant-negative effect.</p>
        <p>Two thirds of the missense pathogenic variants that have been identified are within the highly conserved HMG DNA-binding domain. Functional studies on two of these variants, using a modified yeast one-hybrid system, confirm that these pathogenic variants severely diminish the activation of DC5 delta crystalline enhancer through loss of cooperative <italic toggle="yes">SOX2</italic>/<italic toggle="yes">PAX6</italic> binding [<xref ref-type="bibr" rid="sox2.REF.williamson.2006.1413">Williamson et al 2006</xref>].</p>
      </sec>
      <sec id="sox2.References">
        <title>References</title>
        <sec id="sox2.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="sox2.Literature_Cited.reflist0">
            <ref id="sox2.REF.ambrosetti.2000.23387">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ambrosetti</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scholer</surname>
                    <given-names>HR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dailey</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Basilico</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Modulation of the activity of multiple transcriptional activation domains by the DNA binding domains mediates the synergistic action of Sox2 and Oct-3 on the fibroblast growth factor-4 enhancer.</article-title>
                <source>J Biol Chem</source>
                <volume>275</volume>
                <fpage>23387</fpage>
                <lpage>97</lpage>
                <pub-id pub-id-type="pmid">10801796</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.bakrania.2007.1471">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bakrania</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>DO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bunyan</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crolla</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wyatt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fielder</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ainsworth</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Read</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uddin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laws</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascuel-Salcedo</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayuso</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collin</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ragge</surname>
                    <given-names>NK</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>SOX2 anophthalmia syndrome: 12 new cases demonstrating broader phenotype and high frequency of large gene deletions.</article-title>
                <source>Br J Ophthalmol</source>
                <volume>91</volume>
                <fpage>1471</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17522144</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.chassaing.2013">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chassaing</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Causse</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vigouroux</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delahaye</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alessandri</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boute-Benejean</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dollfus</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duban-Bedu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilbert-Dussardier</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giuliano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzales</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holder-Espinasse</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isidor</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacquemont</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacombe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin-Coignard</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathieu-Dramard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Picone</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quelin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sigaudy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toutain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thauvin-Robinet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calvas</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia.</article-title>
                <source>Clin Genet.</source>
                <year>2013</year>
                <comment>Epub ahead of print</comment>
                <pub-id pub-id-type="pmid">24033328</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.chassaing.2007.289">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chassaing</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilbert-Dussardier</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nicot</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fermeaux</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Encha-Razavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiorenza</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toutain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calvas</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Germinal mosaicism and familial recurrence of a SOX2 mutation with highly variable phenotypic expression extending from AEG syndrome to absence of ocular involvement.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2007</year>
                <volume>143</volume>
                <fpage>289</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">17219395</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.faivre.2006.636">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Faivre</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williamson</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faber</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laurent</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grimaldi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thauvin-Robinet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durand</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mugneret</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gouyon</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bron</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huet</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayward</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heyningen</surname>
                    <given-names>VV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitzpatrick</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <article-title>Recurrence of SOX2 anophthalmia syndrome with gonosomal mosaicism in a phenotypically normal mother.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2006</year>
                <volume>140</volume>
                <fpage>636</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16470798</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.fantes.2003.461">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fantes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ragge</surname>
                    <given-names>NK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lynch</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGill</surname>
                    <given-names>NI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collin</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Howard-Peebles</surname>
                    <given-names>PN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayward</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vivian</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williamson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Heyningen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>FitzPatrick</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutations in SOX2 cause anophthalmia.</article-title>
                <source>Nat Genet</source>
                <volume>33</volume>
                <fpage>461</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">12612584</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.gerthkahlert.2013.15">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gerth-Kahlert</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williamson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ansari</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rainger</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hingst</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmermann</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tech</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guthoff</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Heyningen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitzpatrick</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and mutation analysis of 51 probands with anophthalmia and/or severe microphthalmia from a single center.</article-title>
                <source>Mol Genet Genomic Med.</source>
                <year>2013</year>
                <volume>1</volume>
                <fpage>15</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">24498598</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.gonzalezrodriguez.2010.1100">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gonzalez-Rodriguez</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelcastre</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tovilla-Canales</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Ortiz</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amato-Almanza</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villanueva-Mendoza</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Espinosa-Mattar</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zenteno</surname>
                    <given-names>JC</given-names>
                  </name>
                </person-group>
                <article-title>Mutational screening of CHX10, GDF6, OTX2, RAX and SOX2 genes in 50 unrelated microphthalmia-anophthalmia-coloboma (MAC) spectrum cases.</article-title>
                <source>Br J Ophthalmol.</source>
                <year>2010</year>
                <volume>94</volume>
                <fpage>1100</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20494911</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.guichet.2004.828">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guichet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Triau</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lepinard</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Esculapavit</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biquard</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Descamps</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Encha-Razavi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonneau</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Prenatal diagnosis of primary anophthalmia with a 3q27 interstitial deletion involving SOX2.</article-title>
                <source>Prenat Diagn</source>
                <volume>24</volume>
                <fpage>828</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">15503273</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.hever.2006.459">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hever</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williamson</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Heyningen</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <article-title>Developmental malformations of the eye: the role of PAX6, SOX2 and OTX2.</article-title>
                <source>Clin Genet.</source>
                <year>2006</year>
                <volume>69</volume>
                <fpage>459</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">16712695</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.kamachi.2001.1272">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kamachi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchikawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tanouchi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sekido</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondoh</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Pax6 and SOX2 form a co-DNA-binding partner complex that regulates initiation of lens development.</article-title>
                <source>Genes Dev</source>
                <volume>15</volume>
                <fpage>1272</fpage>
                <lpage>86</lpage>
                <pub-id pub-id-type="pmid">11358870</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.kelberman.2008.1865">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kelberman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Castro</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crolla</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palmer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gregory</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavallo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faienza</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischetto</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Achermann</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez-Barbera</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzoti</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lovell-Badge</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>IC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerrelli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dattani</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>SOX2 plays a critical role in the pituitary, forebrain, and eye during human embryonic development.</article-title>
                <source>J Clin Endocrinol Metab</source>
                <volume>93</volume>
                <fpage>1865</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">18285410</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.kelberman.2006.2442">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kelberman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzoti</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Avilion</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bitner-Glindzicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cianfarani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chong</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirk</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Achermann</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carmignac</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lovell-Badge</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>IC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dattani</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans.</article-title>
                <source>J Clin Invest</source>
                <volume>116</volume>
                <fpage>2442</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">16932809</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.kurbasic.2000.239">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kurbasic</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>FV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cook</surname>
                    <given-names>LN</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Bilateral microphthalmos with colobomatous orbital cyst and de-novo balanced translocation t(3;5).</article-title>
                <source>Ophthalmic Genet</source>
                <volume>21</volume>
                <fpage>239</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">11135495</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.macchiaroli.2014.282">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Macchiaroli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelberman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auriemma</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drury</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Islam</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giangiobbe</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ironi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lench</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sowden</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colao</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pivonello</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavallo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasperi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faienza</surname>
                    <given-names>MF</given-names>
                  </name>
                </person-group>
                <article-title>A novel heterozygous SOX2 mutation causing congenital bilateral anophthalmia, hypogonadotropic hypogonadism and growth hormone deficiency</article-title>
                <source>Gene.</source>
                <year>2014</year>
                <volume>534</volume>
                <fpage>282</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">24211324</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.male.2002.807">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Male</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davies</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergbaum</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keeling</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>FitzPatrick</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackie Ogilvie</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berg</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Delineation of an estimated 6.7 MB candidate interval for an anophthalmia gene at 3q26.33-q28 and description of the syndrome associated with visible chromosome deletions of this region.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>10</volume>
                <fpage>807</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">12461687</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.mihelec.2009.1417">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mihelec</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abraham</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibson</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krowka</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Susman</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Storen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donald</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tam</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grigg</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flaherty</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gole</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jamieson</surname>
                    <given-names>RV</given-names>
                  </name>
                </person-group>
                <article-title>Novel SOX2 partner-factor domain mutation in a four-generation family</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2009</year>
                <volume>17</volume>
                <fpage>1417</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">19471311</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.muta.2002.791">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Muta</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamachi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshimoto</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondoh</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Distinct roles of SOX2, Pax6 and Maf transcription factors in the regulation of lens-specific delta1-crystallin enhancer.</article-title>
                <source>Genes Cells</source>
                <volume>7</volume>
                <fpage>791</fpage>
                <lpage>805</lpage>
                <pub-id pub-id-type="pmid">12167158</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.ragge.2005a.1008">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ragge</surname>
                    <given-names>NK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brown</surname>
                    <given-names>AG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poloschek</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henderson</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarke</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russell-Eggitt</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fielder</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerrelli</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martinez-Barbera</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruddle</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurst</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collin</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cooper</surname>
                    <given-names>ST</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sisodiya</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williamson</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitzpatrick</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Heyningen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanson</surname>
                    <given-names>IM</given-names>
                  </name>
                </person-group>
                <year>2005a</year>
                <article-title>Heterozygous mutations of OTX2 cause severe ocular malformations.</article-title>
                <source>Am J Hum Genet</source>
                <volume>76</volume>
                <fpage>1008</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">15846561</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.ragge.2005b.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ragge</surname>
                    <given-names>NK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bushby</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Sanctis</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Sanctis</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salt</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collin</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vivian</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Free</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williamson</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sisodiya</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Heyningen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitzpatrick</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <year>2005b</year>
                <article-title>SOX2 anophthalmia syndrome.</article-title>
                <source>Am J Med Genet A</source>
                <volume>135</volume>
                <fpage>1</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">15812812</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.schilter.2013.473">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schilter</surname>
                    <given-names>KF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reis</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bardakjian</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdul-Rahman</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kozel</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimmerman</surname>
                    <given-names>HH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Broeckel</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Semina</surname>
                    <given-names>EV</given-names>
                  </name>
                </person-group>
                <article-title>Whole-genome copy number variation analysis in anophthalmia and microphthalmia.</article-title>
                <source>Clin Genet.</source>
                <year>2013</year>
                <volume>84</volume>
                <fpage>473</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">23701296</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.schneider.2009.2706">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bardakjian</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reis</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tyler</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Semina</surname>
                    <given-names>EV</given-names>
                  </name>
                </person-group>
                <article-title>Novel SOX2 mutations and genotype-phenotype correlation in anophthalmia and microphthalmia.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2009</year>
                <volume>149A</volume>
                <fpage>2706</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">19921648</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.schneider.2008.2794">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bardakjian</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keep</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorsainville</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kherani</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katowitz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schimmenti</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hummel</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitzpatrick</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>TL</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Familial recurrence of SOX2 anophthalmia syndrome: phenotypically normal mother with two affected daughters.</article-title>
                <source>Am J Med Genet A</source>
                <volume>146A</volume>
                <fpage>2794</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18831064</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.sisodiya.2006.534">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sisodiya</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ragge</surname>
                    <given-names>NK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cavalleri</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hever</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Williamson</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stevens</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Free</surname>
                    <given-names>SL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thompson</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Heyningen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitzpatrick</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Role of SOX2 mutations in human hippocampal malformations and epilepsy.</article-title>
                <source>Epilepsia</source>
                <volume>47</volume>
                <fpage>534</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">16529618</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.stark.2011.753">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stark</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Storen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennetts</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savarirayan</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jamieson</surname>
                    <given-names>RV</given-names>
                  </name>
                </person-group>
                <article-title>Isolated hypogonadotropic hypogonadism with SOX2 mutation and anophthalmia/microphthalmia in offspring.</article-title>
                <source>Eur J Hum Genet.</source>
                <year>2011</year>
                <volume>19</volume>
                <fpage>753</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21326281</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.takagi.2014.133">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Takagi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Narumi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asakura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muroya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Adachi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hasegawa</surname>
                    <given-names>T.</given-names>
                  </name>
                </person-group>
                <article-title>A novel mutation in SOX2 causes hypogonadotropic hypogonadism with mild ocular malformation.</article-title>
                <source>Horm Res Paediatr.</source>
                <year>2014</year>
                <volume>81</volume>
                <fpage>133</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">24457197</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.tomioka.2002.3202">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tomioka</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyagi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katayanagi</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukui</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niwa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muramatsu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okuda</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex.</article-title>
                <source>Nucleic Acids Res</source>
                <volume>30</volume>
                <fpage>3202</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">12136102</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.tziaferi.2008.194">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tziaferi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelberman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dattani</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>The role of SOX2 in hypogonadotropic hypogonadism.</article-title>
                <source>Sex Dev</source>
                <volume>2</volume>
                <fpage>194</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18987493</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.williamson.2014">
              <mixed-citation publication-type="other">Williamson KA, FitzPatrick DR. The genetic architecture of microphthalmia, anophthalmia and coloboma. Eur J Med Genet. 2014 May 22. pii: S1769-7212(14)00114-1.</mixed-citation>
            </ref>
            <ref id="sox2.REF.williamson.2006.1413">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Williamson</surname>
                    <given-names>KA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hever</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rainger</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rogers</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magee</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fiedler</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Keng</surname>
                    <given-names>WT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sharkey</surname>
                    <given-names>FH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGill</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hill</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Messina</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnpenny</surname>
                    <given-names>PD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fantes</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Heyningen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>FitzPatrick</surname>
                    <given-names>DR</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Mutations in SOX2 cause anophthalmia-esophageal-genital (AEG) syndrome.</article-title>
                <source>Hum Mol Genet</source>
                <volume>15</volume>
                <fpage>1413</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">16543359</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.zenteno.2005.564">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zenteno</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gascon-Guzman</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tovilla-Canales</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Bilateral anophthalmia and brain malformations caused by a 20-bp deletion in the SOX2 gene.</article-title>
                <source>Clin Genet</source>
                <volume>68</volume>
                <fpage>564</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">16283891</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.zenteno.2006.1899">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zenteno</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perez-Cano</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aguinaga</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Anophthalmia-esophageal atresia syndrome caused by an SOX2 gene deletion in monozygotic twin brothers with markedly discordant phenotypes.</article-title>
                <source>Am J Med Genet A</source>
                <volume>140</volume>
                <fpage>1899</fpage>
                <lpage>903</lpage>
                <pub-id pub-id-type="pmid">16892407</pub-id>
              </element-citation>
            </ref>
            <ref id="sox2.REF.zhou.2008.583">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kherani</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bardakjian</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katowitz</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hughes</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schimmenti</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>TL</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Identification of novel mutations and sequence variants in the SOX2 and CHX10 genes in patients with anophthalmia/microphthalmia.</article-title>
                <source>Mol Vis</source>
                <volume>14</volume>
                <fpage>583</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">18385794</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="sox2.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="sox2.Acknowledgments">
          <title>Acknowledgments</title>
          <p>Professor Veronica van Heyningen for continued helpful collaboration</p>
          <p>MACS family support organization for their interest and support</p>
        </sec>
        <sec id="sox2.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>31 July 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>25 August 2009 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>7 March 2008 (cd) Revision: FISH analysis available clinically</p>
            </list-item>
            <list-item>
              <p>5 December 2007 (cd) Revision: deletion/duplication analysis available cl</p>
            </list-item>
            <list-item>
              <p>23 February 2006 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>14 April 2005 (drf) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
